학술논문

A retrospective analysis of cardiovascular morbidity in metastatic hormone-refractory prostate cancer patients on high doses of the selective COX-2 inhibitor celecoxib
Document Type
Journal
Source
EXPERT OPINION ON PHARMACOTHERAPY; JUL 2007, 8 10, p1425-p1431, 7p.
Subject
Language
English
ISSN
14656566